THE METHOD

Treg method is an innovative Polish breakthrough therapy with T-regulatory cells (Treg) obtained from the patient’s blood. Currently, the therapy is used for the treatment of diabetes type 1 in children. Tregs are unique, small fraction of human lymphocytes, which in the autoimmune diseases, such as diabetes type 1, provide immunoprotection against harmful effects and development of the disease. The uniqueness of the treatment lies in reduction of the disease causes, and not only its clinical symptoms, which improves the quality of life and clinical parameters of pediatric patients.

MISSION

PolTREG’s main goal is the implementation of TREG method on the Polish as well as international market. Due to special character of the biotechnology sector (especially red biotechnology, cell therapies) the so called “time-to-market” is much more time-consuming and capital-intensive in comparison to other sectors – requirement for clinical trials, registration processes for safety and well-being of patients.

Technology

From the medical viewpoint, the therapy process begins with the patient’s diagnosis with type 1 diabetes. After medical assessment in hospital, patient is qualified for the programme. At this point, sampling of venous blood is conducted, which will further serve to isolate white blood cells, and from them TREG cells (regulatory T lymphocytes), which after multiplication in sterile laboratory conditions, are subsequently administered to the same patient as a TREG vaccine.

The Method

One of the world’s most advanced therapies for diabetes type 1 using Treg cells.

The Team

The distinguished and award-winning team of professors of medicine (diabetology and immunology) and highly skilled team of managers.

The Strategy

The commercialization of the Treg method on the world markets.

OUR TEAM

INVENTORS OF THE TREG METHOD

OUR TEAM

BOARD MANAGEMENT

Empty Team
Member of the Board
Kamilla Bok
Empty Team
Member of the Board
Mariusz Jabłoński
OUR TEAM

OPERATING TEAM

Empty Team
Board Assistant
Magdalena Dobyszuk
Empty Team
Biotechnologist
MSC Justyna Sakowska
Empty Team
Biotechnologist
Karolina Elżbieta Piekarska
Empty Team
Biotechnologist
Dr. Dorota Iwaszkiewicz-Grześ
Empty Team
Biotechnologist
Dr. Ewa Szmit-Kosińska
Empty Team
Quality Specialist
Anita Dobyszuk
Empty Team
Chief Scientific Officer
Anna Mikosik-Roczyńska

PARTNERS